Global Capecitabine Market Research Report 2026

1 Capecitabine Market Overview
1.1 Product Definition
1.2 Capecitabine by Type
1.2.1 Global Capecitabine Market Value by Type: 2025 vs 2032
1.2.2 500 mg
1.2.3 150 mg
1.3 Capecitabine by Application
1.3.1 Global Capecitabine Market Value by Application: 2025 vs 2032
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.4 Global Capecitabine Market Size Estimates and Forecasts
1.4.1 Global Capecitabine Revenue 2021–2032
1.4.2 Global Capecitabine Sales 2021–2032
1.4.3 Global Capecitabine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Capecitabine Market Competition by Manufacturers
2.1 Global Capecitabine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Capecitabine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Capecitabine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Capecitabine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Capecitabine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Capecitabine, Product Types and Applications
2.7 Global Key Manufacturers of Capecitabine, Date of Entry into the Industry
2.8 Global Capecitabine Market Competitive Situation and Trends
2.8.1 Global Capecitabine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Capecitabine Players Market Share by Revenue
2.8.3 Global Capecitabine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Capecitabine Market Scenario by Region
3.1 Global Capecitabine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Capecitabine Sales by Region: 2021–2032
3.2.1 Global Capecitabine Sales by Region: 2021–2026
3.2.2 Global Capecitabine Sales by Region: 2027–2032
3.3 Global Capecitabine Revenue by Region: 2021–2032
3.3.1 Global Capecitabine Revenue by Region: 2021–2026
3.3.2 Global Capecitabine Revenue by Region: 2027–2032
3.4 North America Capecitabine Market Facts & Figures by Country
3.4.1 North America Capecitabine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Capecitabine Sales by Country (2021–2032)
3.4.3 North America Capecitabine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Capecitabine Market Facts & Figures by Country
3.5.1 Europe Capecitabine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Capecitabine Sales by Country (2021–2032)
3.5.3 Europe Capecitabine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Capecitabine Market Facts & Figures by Region
3.6.1 Asia Pacific Capecitabine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Capecitabine Sales by Region (2021–2032)
3.6.3 Asia Pacific Capecitabine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Capecitabine Market Facts & Figures by Country
3.7.1 Latin America Capecitabine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Capecitabine Sales by Country (2021–2032)
3.7.3 Latin America Capecitabine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Capecitabine Market Facts & Figures by Country
3.8.1 Middle East and Africa Capecitabine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Capecitabine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Capecitabine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Capecitabine Sales by Type (2021–2032)
4.1.1 Global Capecitabine Sales by Type (2021–2026)
4.1.2 Global Capecitabine Sales by Type (2027–2032)
4.1.3 Global Capecitabine Sales Market Share by Type (2021–2032)
4.2 Global Capecitabine Revenue by Type (2021–2032)
4.2.1 Global Capecitabine Revenue by Type (2021–2026)
4.2.2 Global Capecitabine Revenue by Type (2027–2032)
4.2.3 Global Capecitabine Revenue Market Share by Type (2021–2032)
4.3 Global Capecitabine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Capecitabine Sales by Application (2021–2032)
5.1.1 Global Capecitabine Sales by Application (2021–2026)
5.1.2 Global Capecitabine Sales by Application (2027–2032)
5.1.3 Global Capecitabine Sales Market Share by Application (2021–2032)
5.2 Global Capecitabine Revenue by Application (2021–2032)
5.2.1 Global Capecitabine Revenue by Application (2021–2026)
5.2.2 Global Capecitabine Revenue by Application (2027–2032)
5.2.3 Global Capecitabine Revenue Market Share by Application (2021–2032)
5.3 Global Capecitabine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Capecitabine Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Capecitabine Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Capecitabine Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hikma Capecitabine Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Company Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hengrui Medicine Capecitabine Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cipla Capecitabine Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Reliance Group
6.7.1 Reliance Group Company Information
6.7.2 Reliance Group Description and Business Overview
6.7.3 Reliance Group Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Reliance Group Capecitabine Product Portfolio
6.7.5 Reliance Group Recent Developments/Updates
6.8 Hetero
6.8.1 Hetero Company Information
6.8.2 Hetero Description and Business Overview
6.8.3 Hetero Capecitabine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hetero Capecitabine Product Portfolio
6.8.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Capecitabine Industry Chain Analysis
7.2 Capecitabine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Capecitabine Production Mode & Process Analysis
7.4 Capecitabine Sales and Marketing
7.4.1 Capecitabine Sales Channels
7.4.2 Capecitabine Distributors
7.5 Capecitabine Customer Analysis
8 Capecitabine Market Dynamics
8.1 Capecitabine Industry Trends
8.2 Capecitabine Market Drivers
8.3 Capecitabine Market Challenges
8.4 Capecitabine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Capecitabine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Capecitabine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Capecitabine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Capecitabine Sales (Kg) of Key Manufacturers (2021–2026)
Table 5. Global Capecitabine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Capecitabine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Capecitabine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Capecitabine Average Price (USD/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Capecitabine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Capecitabine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Capecitabine, Product Types and Applications
Table 12. Global Key Manufacturers of Capecitabine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Capecitabine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Capecitabine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Capecitabine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Capecitabine Sales by Region (Kg), 2021–2026
Table 18. Global Capecitabine Sales Market Share by Region (2021–2026)
Table 19. Global Capecitabine Sales by Region (Kg), 2027–2032
Table 20. Global Capecitabine Sales Market Share by Region (2027–2032)
Table 21. Global Capecitabine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Capecitabine Revenue Market Share by Region (2021–2026)
Table 23. Global Capecitabine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Capecitabine Revenue Market Share by Region (2027–2032)
Table 25. North America Capecitabine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Capecitabine Sales by Country (Kg), 2021–2026
Table 27. North America Capecitabine Sales by Country (Kg), 2027–2032
Table 28. North America Capecitabine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Capecitabine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Capecitabine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Capecitabine Sales by Country (Kg), 2021–2026
Table 32. Europe Capecitabine Sales by Country (Kg), 2027–2032
Table 33. Europe Capecitabine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Capecitabine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Capecitabine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Capecitabine Sales by Region (Kg), 2021–2026
Table 37. Asia Pacific Capecitabine Sales by Region (Kg), 2027–2032
Table 38. Asia Pacific Capecitabine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Capecitabine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Capecitabine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Capecitabine Sales by Country (Kg), 2021–2026
Table 42. Latin America Capecitabine Sales by Country (Kg), 2027–2032
Table 43. Latin America Capecitabine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Capecitabine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Capecitabine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Capecitabine Sales by Country (Kg), 2021–2026
Table 47. Middle East and Africa Capecitabine Sales by Country (Kg), 2027–2032
Table 48. Middle East and Africa Capecitabine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Capecitabine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Capecitabine Sales (Kg) by Type (2021–2026)
Table 51. Global Capecitabine Sales (Kg) by Type (2027–2032)
Table 52. Global Capecitabine Sales Market Share by Type (2021–2026)
Table 53. Global Capecitabine Sales Market Share by Type (2027–2032)
Table 54. Global Capecitabine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Capecitabine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Capecitabine Revenue Market Share by Type (2021–2026)
Table 57. Global Capecitabine Revenue Market Share by Type (2027–2032)
Table 58. Global Capecitabine Price (USD/g) by Type (2021–2026)
Table 59. Global Capecitabine Price (USD/g) by Type (2027–2032)
Table 60. Global Capecitabine Sales (Kg) by Application (2021–2026)
Table 61. Global Capecitabine Sales (Kg) by Application (2027–2032)
Table 62. Global Capecitabine Sales Market Share by Application (2021–2026)
Table 63. Global Capecitabine Sales Market Share by Application (2027–2032)
Table 64. Global Capecitabine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Capecitabine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Capecitabine Revenue Market Share by Application (2021–2026)
Table 67. Global Capecitabine Revenue Market Share by Application (2027–2032)
Table 68. Global Capecitabine Price (USD/g) by Application (2021–2026)
Table 69. Global Capecitabine Price (USD/g) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 73. Roche Capecitabine Product
Table 74. Roche Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 78. Teva Capecitabine Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 83. Mylan Capecitabine Product
Table 84. Mylan Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 88. Hikma Capecitabine Product
Table 89. Hikma Recent Developments/Updates
Table 90. Hengrui Medicine Company Information
Table 91. Hengrui Medicine Description and Business Overview
Table 92. Hengrui Medicine Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 93. Hengrui Medicine Capecitabine Product
Table 94. Hengrui Medicine Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 98. Cipla Capecitabine Product
Table 99. Cipla Recent Developments/Updates
Table 100. Reliance Group Company Information
Table 101. Reliance Group Description and Business Overview
Table 102. Reliance Group Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 103. Reliance Group Capecitabine Product
Table 104. Reliance Group Recent Developments/Updates
Table 105. Hetero Company Information
Table 106. Hetero Description and Business Overview
Table 107. Hetero Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g), and Gross Margin (2021–2026)
Table 108. Hetero Capecitabine Product
Table 109. Hetero Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Capecitabine Distributors List
Table 113. Capecitabine Customers List
Table 114. Capecitabine Market Trends
Table 115. Capecitabine Market Drivers
Table 116. Capecitabine Market Challenges
Table 117. Capecitabine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report


List of Figures
Figure 1. Product Picture of Capecitabine
Figure 2. Global Capecitabine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Capecitabine Market Share by Type: 2025 & 2032
Figure 4. 500 mg Product Picture
Figure 5. 150 mg Product Picture
Figure 6. Global Capecitabine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Capecitabine Market Share by Application: 2025 & 2032
Figure 8. Breast Cancer
Figure 9. Colorectal Cancer
Figure 10. Stomach Cancer
Figure 11. Global Capecitabine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Capecitabine Market Size (US$ Million), 2021–2032
Figure 13. Global Capecitabine Sales (Kg), 2021–2032
Figure 14. Global Capecitabine Average Price (USD/g), 2021–2032
Figure 15. Capecitabine Report Years Considered
Figure 16. Capecitabine Sales Share by Manufacturers in 2025
Figure 17. Global Capecitabine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Capecitabine Players: Market Share by Revenue in Capecitabine in 2025
Figure 19. Capecitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Capecitabine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Capecitabine Sales Market Share by Country (2021–2032)
Figure 22. North America Capecitabine Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Capecitabine Sales Market Share by Country (2021–2032)
Figure 26. Europe Capecitabine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Capecitabine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Capecitabine Revenue Market Share by Region (2021–2032)
Figure 34. China Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Capecitabine Sales Market Share by Country (2021–2032)
Figure 45. Latin America Capecitabine Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Capecitabine Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Capecitabine Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. U.A.E Capecitabine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Capecitabine by Type (2021–2032)
Figure 55. Global Revenue Market Share of Capecitabine by Type (2021–2032)
Figure 56. Global Capecitabine Price (USD/g) by Type (2021–2032)
Figure 57. Global Sales Market Share of Capecitabine by Application (2021–2032)
Figure 58. Global Revenue Market Share of Capecitabine by Application (2021–2032)
Figure 59. Global Capecitabine Price (USD/g) by Application (2021–2032)
Figure 60. Capecitabine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit